BioCentury

Current Editions

Bolstering the U.S. bioeconomy: a Q&A with Rep. Auchincloss

A Biosecure Act co-sponsor, Massachusetts lawmaker seeks to shape life sciences policy

Politics, Policy & Law

Data Byte

No bounce for Chinese shares after Biosecure changes 

Modest gains for WuXi AppTec fail to materialize for WuXi Biologics

Politics, Policy & Law

Biosecure revised, and venture rounds, deals of note: a BioCentury podcast

What’s new in legislation seeking to rein in influence of China’s CDMOs

Deals

Deals Report: Sanofi-Novavax to co-commercialize Nuvaxovid, develop combination vaccines

Plus: Maze finds Pompe disease program partner in Shionogi, and updates from Takeda-AC Immune, Sanofi-Fulcrum and more

Management Tracks

John Milad named CEO of CRISPR play ERS Genomics

Plus: Senhwa hires Jason Huang as CMO, and updates from Egle and The Jackson Laboratory

BioCentury ISSN 1097-7201